• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胰岛素增敏剂与尿酸代谢]

[Insulin sensitizer and urate metabolism].

作者信息

Iwatani M, Wasada T, Iwamoto Y, Kamatani N

机构信息

Institute of Rheumatology, Tokyo Women's Medical University.

出版信息

Nihon Rinsho. 2000 Feb;58(2):430-4.

PMID:10707571
Abstract

Gout patients often have various characteristics of insulin resistance (IR) syndrome such as glucose intolerance, hyperlipidemia, hypertension and obesity. In addition, epidemiological data suggest that hyperuricemia is associated with higher rates of death due to cardiovascular and cerebrovascular disorders. However, it has not conclusively been shown whether the association between hyperuricemia and increased death rate is secondary to the association between IR and death or hyperuricemia itself is an independent risk of death. It is of interest to examine the effects of insulin sensitizer which was developed recently on serum urate concentration because it may provide a new idea as to the mechanism of the association between IR, hyperuricemia and vascular disorders. In the present paper, we discuss the relevance of IR to hyperuricemia and gout, and show the data of urate and glucose metabolism obtained from control subjects or the patients with hyperuricemia, gout or type 2 diabetes.

摘要

痛风患者常具有胰岛素抵抗(IR)综合征的各种特征,如糖耐量异常、高脂血症、高血压和肥胖。此外,流行病学数据表明,高尿酸血症与心血管和脑血管疾病导致的较高死亡率相关。然而,高尿酸血症与死亡率增加之间的关联是继发于IR与死亡之间的关联,还是高尿酸血症本身就是死亡的独立风险,尚未得到确凿证实。研究最近开发的胰岛素增敏剂对血清尿酸盐浓度的影响很有意义,因为这可能为IR、高尿酸血症和血管疾病之间关联的机制提供新思路。在本文中,我们讨论了IR与高尿酸血症和痛风的相关性,并展示了从对照组或高尿酸血症、痛风或2型糖尿病患者获得的尿酸和葡萄糖代谢数据。

相似文献

1
[Insulin sensitizer and urate metabolism].[胰岛素增敏剂与尿酸代谢]
Nihon Rinsho. 2000 Feb;58(2):430-4.
2
The role of troglitazone in treating the insulin resistance syndrome.曲格列酮在治疗胰岛素抵抗综合征中的作用。
Pharmacotherapy. 1998 Sep-Oct;18(5):973-87.
3
[Uric acid metabolism and insulin resistance in type 2 diabetes].
Nihon Rinsho. 2002 Aug;60 Suppl 8:167-72.
4
Effects of troglitazone on insulin sensitivity.曲格列酮对胰岛素敏感性的影响。
Diabet Med. 1996 Sep;13(9 Suppl 6):S148-50.
5
[Cardiovascular effects of the thiazolidinedione troglitazone].
Nihon Rinsho. 2000 Feb;58(2):435-9.
6
Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent.
Am J Hypertens. 2002 Aug;15(8):697-701. doi: 10.1016/s0895-7061(02)02953-9.
7
Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.曲格列酮可改善II型糖尿病患者的全身胰岛素抵抗及骨骼肌对葡萄糖的利用。
J Nucl Med. 2001 Jul;42(7):1005-10.
8
Thiazolidinediones, dyslipidaemia and insulin resistance syndrome.
Curr Opin Lipidol. 2000 Aug;11(4):397-402. doi: 10.1097/00041433-200008000-00009.
9
Insulin resistance syndrome: options for treatment.胰岛素抵抗综合征:治疗选择
South Med J. 1999 Jan;92(1):2-15. doi: 10.1097/00007611-199901000-00002.
10
[Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].α-葡萄糖苷酶抑制剂与胰岛素增敏剂联合治疗2型糖尿病患者的疗效
Nihon Rinsho. 2002 Sep;60 Suppl 9:464-9.